{"id":3932,"company":{"country":"US","currency":"USD","exchange":"NASDAQ NMS - GLOBAL MARKET","ipo":"2019-06-27","marketCap":2788.7099609375,"name":"Morphic Holding Inc","phone":"17819960955","outstanding":50.09000015258789,"symbol":"MORF","website":"https://morphictx.com/","industry":"Biotechnology"},"price":55.72,"year":2024,"month":7,"day":10,"weekday":"Wednesday","title":"The Impact of Market Sentiment on Morphic Holding Inc Stock's Price Movements","date":"2024-07-10","url":"/posts/2024/07/10/MORF","content":[{"section":"Positive Market Sentiment","text":"During periods of positive market sentiment, investors have a optimistic outlook and confidence in the market. This often leads to increased buying activity and demand for stocks, including Morphic Holding Inc. As a result, the stock price tends to rise during such periods. Historical data can show upward price trends during times of positive market sentiment."},{"section":"Negative Market Sentiment","text":"Conversely, when market sentiment is negative, investors have a pessimistic view and lack confidence in the market. This typically leads to selling pressure and decreased demand for stocks, including Morphic Holding Inc. Consequently, the stock price tends to decline during periods of negative market sentiment. Historical data can demonstrate downward price trends during times of negative market sentiment."},{"section":"Volatility and Market Sentiment","text":"Market sentiment can also influence the level of volatility in Morphic Holding Inc stock. During periods of heightened market sentiment, such as significant news events or economic uncertainty, the stock price may experience larger price swings and increased volatility. This can be observed in historical data, where spikes in volatility coincide with shifts in market sentiment."},{"section":"Influence of External Factors","text":"Market sentiment can be influenced by various external factors, such as macroeconomic indicators, industry trends, company-specific news, and investor sentiment towards related sectors or stocks. These factors can shape the overall market sentiment and subsequently impact the price movements of Morphic Holding Inc stock. Historical data can reveal correlations between these external factors and changes in market sentiment and stock price."},{"section":"Long-Term Effects","text":"While market sentiment can have a significant impact on short-term price movements of Morphic Holding Inc stock, it is important to note that long-term fundamentals and company-specific factors also play a crucial role. Investors' overall sentiment towards the stock may fluctuate over time, but the underlying financial performance and prospects of Morphic Holding Inc ultimately determine its long-term trajectory. Historical data can provide insights into the interplay between market sentiment and long-term stock performance."},{"section":"Interpreting Historical Data","text":"To examine the impact of market sentiment on Morphic Holding Inc stock's price movements using historical data, one can analyze the correlation between market sentiment indicators, such as market indices or sentiment surveys, and the corresponding stock price data. By identifying patterns and trends, one can gain insights into how market sentiment affects the stock's price. It is important to avoid speculative language and rely on objective analysis of the data."},{"section":"Conclusion","text":"Market sentiment, as reflected in historical data, has a notable impact on the price movements of Morphic Holding Inc stock. Positive market sentiment tends to drive the stock price higher, while negative sentiment leads to price declines. Volatility can also increase during periods of shifting market sentiment. External factors and long-term fundamentals also influence market sentiment and stock performance. By analyzing historical data objectively, one can better understand the relationship between market sentiment and Morphic Holding Inc stock's price movements."},{"section":"References","text":"Insert relevant references here."}],"tags":["CrossOver21","Long","Biotechnology"],"news":[{"category":"company","date":1720546385,"headline":"MORPHIC HOLDING INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick \u0026 Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Morphic Holding, Inc. - MORF","id":128641463,"image":"","symbol":"MORF","publisher":"Finnhub","summary":"Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick \u0026 Foti, LLC are investigating the proposed sale of Morphic Holding, Inc. to Eli Lilly and Company ....","url":"https://finnhub.io/api/news?id=3cc8e18d8c24f06b4fc3d1caeaa6d367181ca95de782bb5bf2e2c3e0ce1ed5c0"},{"category":"company","date":1720521900,"headline":"Stocks Are on a Record-Setting Tear. Where They Go From Here and 4 Other Things to Know Today.","id":128635560,"image":"https://s.yimg.com/ny/api/res/1.2/g757Gpg6eBFvDPUL89Vaew--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02MDA-/https://media.zenfs.com/en/Barrons.com/ab54cbf8c97dd677e0cc59f0632d9897","symbol":"MORF","publisher":"Yahoo","summary":"Southwest rebuffs activist Elliott’s threat to appeal directly to shareholders, Eli Lilly is buying Morphic to expand bowel-disease portfolio, and more news to start your day.","url":"https://finance.yahoo.com/m/b9fd442e-22f6-3bc4-9bd5-3622c9f34e3e/stocks-are-on-a.html"},{"category":"company","date":1720517939,"headline":"What Eli Lilly Is Getting With The Acquisition Of Morphic Holding","id":128635879,"image":"","symbol":"MORF","publisher":"SeekingAlpha","summary":"","url":"https://seekingalpha.com/article/4703137-what-eli-lilly-is-getting-with-the-acquisition-of-morphic-holding"},{"category":"company","date":1720469650,"headline":"Eli Lilly Snaps Up Morphic For $3.2 Billion; Morphic Stock Hits The Stratosphere","id":128625730,"image":"https://media.zenfs.com/en/ibd.com/14000fb4847f7ffbf79b2ee54cf036bd","symbol":"MORF","publisher":"Yahoo","summary":"Eli Lilly said Monday it would acquire Morphic Holding for $3.2 billion, and Morphic stock skyrocketed to a 10-month high.","url":"https://finance.yahoo.com/m/b6d40a3f-f364-34e0-b521-4a0adac930ce/eli-lilly-snaps-up-morphic.html"},{"category":"company","date":1720469121,"headline":"US Equities Markets End Mixed as Investors Await Inflation Data","id":128625731,"image":"https://s.yimg.com/cv/apiv2/social/images/yahoo_default_logo-1200x1200.png","symbol":"MORF","publisher":"Yahoo","summary":"US Equities Markets End Mixed as Investors Await Inflation Data","url":"https://finance.yahoo.com/news/us-equities-markets-end-mixed-200521607.html"},{"category":"company","date":1720458798,"headline":"Lilly bolsters IBD portfolio with $3.2bn Morphic acquisition","id":128624088,"image":"https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2024/07/shutterstock_2154029791-1-e1720455745531.jpg","symbol":"MORF","publisher":"Yahoo","summary":"Morphic’s lead asset MORF-057 is being investigated in three IBD clinical trials, with data in ulcerative colitis expected next year.","url":"https://www.pharmaceutical-technology.com/news/lilly-bolsters-ibd-portfolio-with-3-2bn-morphic-acquisition/"},{"category":"company","date":1720429093,"headline":"Stocks to Watch Monday: Paramount, Boeing, Carlsberg","id":128621004,"image":"https://s.yimg.com/ny/api/res/1.2/r3J55NDOwdUJ.LUt.H_McQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02MDA-/https://media.zenfs.com/en/wsj.com/fda16fa5528d8a35e64c00ba7fc0e833","symbol":"MORF","publisher":"Yahoo","summary":"**?** **Boeing (BA)**: The world's biggest aerospace company agreed to plead guilty to misleading air-safety regulators in the run-up to two deadly 737 MAX crashes. **↗️** **Paramount Global (PARA)**: The Hollywood company agreed to merge with David Ellison's Skydance Media, ending a nearly four-decade run by the Redstone family as entertainment power players.","url":"https://finance.yahoo.com/m/8c4618dc-8507-34ff-9418-42da5247439b/stocks-to-watch-monday%3A.html"},{"category":"company","date":1720454856,"headline":"Biden, Boeing plea deal, French markets: Morning Brief","id":128624512,"image":"https://s.yimg.com/ny/api/res/1.2/4P4msHMtiHEwhVHPXsig4w--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzY-/https://s.yimg.com/os/creatr-uploaded-images/2024-07/19a61540-3d44-11ef-afaf-ac6b8178332b","symbol":"MORF","publisher":"Yahoo","summary":"It's Monday morning, and stocks (^DJI, ^IXIC, ^GSPC) are moving as if they're on their third cup of coffee ahead of the market opening. Seana Smith and Brad Smith help investors start the day off right, highlighting this morning's top business stories and previewing the biggest economic data prints and earnings reports expected out throughout the week. Raymond James managing director Ed Mills comes onto The Morning Brief to talk about how the markets could react to President Biden's willingness to stay in the 2024 presidential election. Boeing (BA) plans to plead guilty to a fraud charge tied to fatal 737 Max crashes from 2018 and 2019. Bloomberg Intelligence senior analyst George Ferguson expands upon the plea deal arranged with the Department of Justice (DOJ) and what it means for the aerospace company's stock value after a series of manufacturing issues from the beginning of 2024. Several other top trending stocks on the Yahoo Finance platform include Paramount Global (PARA) as the media company agrees to an $8 billion merger with Skydance Media; Eli Lilly (LLY) $3.2 billion acquisition of Morphic Holding (MORF); and French indexes (^FCHI, ^SBF120) in response to the country's snap election results. This post was written by Luke Carberry Mogan.","url":"https://finance.yahoo.com/video/biden-boeing-plea-deal-french-160736322.html"},{"category":"company","date":1720454323,"headline":"Top Midday Stories: Boeing Reaches Settlement with DOJ Over Fatal 737 Max Crashes; Eli Lilly Acquires Morphic for $3.2 Billion; Paramount to Merge with Skydance","id":128625736,"image":"https://s.yimg.com/cv/apiv2/social/images/yahoo_default_logo-1200x1200.png","symbol":"MORF","publisher":"Yahoo","summary":"Top Midday Stories: Boeing Reaches Settlement with DOJ Over Fatal 737 Max Crashes; Eli Lilly Acquires Morphic for $3.2 Billion; Paramount to Merge with Skydance","url":"https://finance.yahoo.com/news/top-midday-stories-boeing-reaches-155843944.html"},{"category":"company","date":1720439197,"headline":"Lilly Agrees to Buy US Biotech Morphic in $3.2 Billion Deal","id":128622085,"image":"https://s.yimg.com/ny/api/res/1.2/.zLWfzQIi6SHKOe4z_wdWQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/bloomberg_markets_842/6fea507415b181651b085256bca91d8f","symbol":"MORF","publisher":"Yahoo","summary":"(Bloomberg) -- Eli Lilly \u0026 Co. agreed to buy U.S. gut-drug maker Morphic Holding Inc. for about $3.2 billion, plowing some of the proceeds from obesity blockbuster Zepbound into its experimental pipeline. Most Read from BloombergBiden Narrows Gap With Trump in Swing States Despite Debate LossBoeing to Plead Guilty to Fraud for Violating Deal Over 737 Max CrashesHedge Funds That Piled Into Big Tesla Short Stung by RallyMicrosoft Orders China Staff to Use iPhones for Work and Drop AndroidOld Schoo","url":"https://finance.yahoo.com/news/lilly-agrees-buy-us-biotech-110605998.html"},{"category":"company","date":1720446969,"headline":"Eli Lilly to acquire Morphic in $3.2B deal","id":128622077,"image":"https://s.yimg.com/ny/api/res/1.2/eIO44wZP9QlMk4wYL17LUw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzU-/https://s.yimg.com/os/creatr-uploaded-images/2024-07/0fffd110-3d31-11ef-bf6f-8a971c54081a","symbol":"MORF","publisher":"Yahoo","summary":"Pharmaceutical giant Eli Lilly (LLY) has reached an agreement to purchase biopharmaceutical company Morphic (MORF) in a deal valued at $3.2 billion. This strategic move marks a notable expansion in Eli Lilly's portfolio and research capabilities. Yahoo Finance health reporter Anjalee Khemlani explores the benefits of this deal for both companies and the broader pharmaceutical industry. For more expert insight and the latest market action, click here to watch this full episode of Morning Brief. This article was written by Angel Smith","url":"https://finance.yahoo.com/video/eli-lilly-acquire-morphic-3-135609253.html"},{"category":"company","date":1720446480,"headline":"Eli Lilly to Buy Morphic for $3.2 Billion. Morphic Stock Nearly Doubles.","id":128622080,"image":"https://s.yimg.com/ny/api/res/1.2/P.MTH5pfBuwKBXKm6zxzSQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02MDA-/https://media.zenfs.com/en/Barrons.com/1333e94ebdca7154c4d000415db7cc6e","symbol":"MORF","publisher":"Yahoo","summary":"Eli Lilly agrees to pay $57 a share for Morphic, a 79% premium to the stock’s closing price of $31.84 on Friday.","url":"https://finance.yahoo.com/m/4c440ee7-62f4-350b-9027-2b8d4da14b5e/eli-lilly-to-buy-morphic-for.html"},{"category":"company","date":1720446243,"headline":"Eli Lilly Buys Morphic for $3.2B","id":128625740,"image":"https://www.investopedia.com/thmb/7Z1jyTor33duOYn0wd7QgQM8dAk=/1500x0/filters:no_upscale():max_bytes(150000):strip_icc()/GettyImages-2157849824-eaf23b3aa9c84c3eaadb2e9cec964740.jpg","symbol":"MORF","publisher":"Yahoo","summary":"Eli Lilly agreed to buy biopharmaceutical firm Morphic for roughly $3.2 billion, sending shares of Morphic skyrocketing Monday.","url":"https://www.investopedia.com/eli-lilly-buys-morphic-for-usd3-2b-8674489"},{"category":"company","date":1720443978,"headline":"Eli Lilly Strikes $3.2 Billion Deal to Acquire Morphic","id":128622081,"image":"https://media.zenfs.com/en/mt_newswires_premium_news_706/6fcb0e4daa23894ba9c15e5da184e3ec","symbol":"MORF","publisher":"Yahoo","summary":"Eli Lilly Strikes $3.2 Billion Deal to Acquire Morphic","url":"https://finance.yahoo.com/news/eli-lilly-strikes-3-2-130618038.html"},{"category":"company","date":1720441852,"headline":"Eli Lilly Targets IBD, Takes Calculated Gamble With $3.2bn Morphic Deal","id":128623178,"image":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1751985252/image_1751985252.jpg?io=getty-c-w1536","symbol":"MORF","publisher":"SeekingAlpha","summary":"Eli Lilly is set to acquire Morphic for $3.2bn. Click here to read why I think this is an important deal for LLY for the diversification of its revenue sources.","url":"https://seekingalpha.com/article/4702966-eli-lilly-targets-ibd-takes-calculated-gamble-with-3-2bn-morphic-deal"},{"category":"company","date":1720441560,"headline":"Lilly to buy Morphic in $3B bet on inflammation drug","id":128625742,"image":"https://www.biopharmadive.com/imgproxy/Rl8EriSft-P1xuObZ2-zhmWvIoSO-LoJ-f_FTa-xfHA/g:ce/rs:fit:770:435/bG9jYWw6Ly8vZGl2ZWltYWdlL0dldHR5SW1hZ2VzLTEzNTU2NTYzMjAuanBn.webp","symbol":"MORF","publisher":"Yahoo","summary":"The deal would hand Lilly an experimental pill that could one day rival Takeda's blockbuster medicine Entyvio as a treatment for inflammatory bowel disease.","url":"https://www.biopharmadive.com/news/lilly-morphic-acquire-deal-ibd-colitis-crohns/720676/"},{"category":"company","date":1720441260,"headline":"Morphic Holding, Boeing rise; Paramount, Devon Energy fall, Monday, 7/8/2024","id":128626029,"image":"","symbol":"MORF","publisher":"Associated Press, The","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=lb8794notf"},{"category":"company","date":1720440480,"headline":"Wall Street Lunch: Merger Monday In All Its Glory","id":128622902,"image":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1097298712/image_1097298712.jpg?io=getty-c-w1536","symbol":"MORF","publisher":"SeekingAlpha","summary":"Carlsberg (CABGY) seals acquisition of U.K. soft drinks company Britvic, Lilly to buy Morphic Holding","url":"https://seekingalpha.com/article/4702957-wall-street-lunch-merger-monday-in-all-its-glory"},{"category":"company","date":1720437360,"headline":"Eli Lilly to Buy Morphic Holding for $3.2 Billion","id":128622088,"image":"https://s.yimg.com/ny/api/res/1.2/3X00q_vNThqn0M1G29kCOg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02MDA-/https://media.zenfs.com/en/wsj.com/78dafe14d3cf3dbe78f8cb6acbdec159","symbol":"MORF","publisher":"Yahoo","summary":"Eli Lilly has agreed to buy biopharmaceutical company Morphic Holding for $3.2 billion in a deal that bolsters the drugmaker’s immunology pipeline.","url":"https://finance.yahoo.com/m/d14fab61-c3cd-3802-ac25-c74d3b6e0cf2/eli-lilly-to-buy-morphic.html"},{"category":"company","date":1720435948,"headline":"Lilly beefs up bowel disease drug portfolio with $3.2 billion Morphic deal","id":128622090,"image":"https://media.zenfs.com/en/reuters.com/05baaf4d8cf7d90f9a02030f348ffc05","symbol":"MORF","publisher":"Yahoo","summary":"(Reuters) -Eli Lilly agreed to buy Morphic Holding for  $3.2 billion in cash, the companies said on Monday, beefing up its portfolio of inflammatory bowel disease (IBD) drugs and expanding its footprint in the multi-billion dollar market.  Shares of Waltham, Massachusetts-based Morphic surged 76% to $56.15 in premarket trading on Lilly's offer of $57 per share, which represents a 79% premium to stock's last closing price.  Through the deal, Lilly will procure an experimental oral IBD treatment that offers patients a more convenient dosing option compared to other injectable therapies, including its IBD drug Omvoh that was approved last year.","url":"https://ca.finance.yahoo.com/news/eli-lilly-acquire-morphic-holding-105228695.html"},{"category":"company","date":1720435500,"headline":"Lilly to Acquire Morphic to Improve Outcomes for Patients with Inflammatory Bowel Disease","id":128622091,"image":"https://media.zenfs.com/en/prnewswire.com/df345efe9aaf8625c1224e8763d43e53","symbol":"MORF","publisher":"Yahoo","summary":"Eli Lilly and Company (NYSE: LLY) and Morphic Holding, Inc. (NASDAQ: MORF) today announced a definitive agreement for Lilly to acquire Morphic, a biopharmaceutical company developing oral integrin therapies for treatment of serious chronic diseases.","url":"https://finance.yahoo.com/news/lilly-acquire-morphic-improve-outcomes-104500467.html"},{"category":"company","date":1720435027,"headline":"Shareholder Alert: Ademi LLP investigates whether Morphic Holding, Inc. has obtained a Fair Price for its Public Shareholders","id":128622251,"image":"","symbol":"MORF","publisher":"Finnhub","summary":"MILWAUKEE, July 8, 2024 /PRNewswire/ -- Ademi LLP is investigating Morphic  for possible breaches of fiduciary duty and other violations of law in its transaction with Lilly. ...","url":"https://finnhub.io/api/news?id=c6dc1b9691878b985362a10fc4bfc9e76d189350a36b4b49821ca336b410e3e8"},{"category":"company","date":1720433777,"headline":"Morphic Holding Shares Take Flight on Acquisition by Eli Lilly","id":128622113,"image":"","symbol":"MORF","publisher":"Finnhub","summary":"By Colin Kellaher Morphic Holding shares surged 75% in early trading Monday after the biopharmaceutical company agreed to be acquired by drugmaker Eli Lilly for $3.2 billion in cash. Eli...","url":"https://finnhub.io/api/news?id=120a83c47ee1fad94a6a7c8f3e65f2981a78e0685d3be2ebea278722b6ab588f"},{"category":"company","date":1720429870,"headline":"MORF Alert: Monsey Firm of Wohl \u0026 Fruchter Investigating Fairness of the Sale of Morphic Holding to Eli Lilly","id":128621807,"image":"","symbol":"MORF","publisher":"Finnhub","summary":"MONSEY, N.Y., July 08, 2024 -- The law firm of Wohl \u0026 Fruchter LLP is investigating the fairness of the proposed sale of Morphic Holding, Inc. to Eli Lilly and Company for $57.00 per share in...","url":"https://finnhub.io/api/news?id=ff36c183c88bb6249e04ce5047bad2441665a5ca6b6ee6edd99ef01eb5229766"},{"category":"company","date":1720424046,"headline":"MORF Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Morphic Holding, Inc. Is Fair to Shareholders","id":128620933,"image":"","symbol":"MORF","publisher":"Finnhub","summary":"Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Morphic Holding, Inc. to Eli Lilly and Company for $57.00 per share in cash is fair to Morphic...","url":"https://finnhub.io/api/news?id=34f4d41890b0556650063942332dfae566321d46e3960894273580b0ef282d56"},{"category":"company","date":1720421881,"headline":"Eli Lilly to buy bowel disease drug developer Morphic for $3.2 bln","id":128620611,"image":"","symbol":"MORF","publisher":"Finnhub","summary":"Eli Lilly will acquireMorphic Holding for $3.2 billion, the companies saidon Monday, giving the U.S. drugmaker access to an experimentaldrug for inflammatory bowel disease. Shares of...","url":"https://finnhub.io/api/news?id=12df2fe638e6c573e9c6ba47f47196f9bf26f2a9ab0468a1e8f776e3694c4af7"}]}